SINT - Sintx Technologies, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Salt Lake City,
United States
Type: Equity
SINT price evolution
SINT
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $4.56 | $5.76 | $3.34 | |
| Short term investments | ||||
| Net receivables | $0.34 | $0.43 | $0.48 | $0.69 |
| Inventory | $0.46 | $1.02 | $1.18 | $1.22 |
| Total current assets | $6.33 | $5.86 | $7.51 | $5.53 |
| Long term investments | ||||
| Property, plant & equipment | $4.32 | $8.61 | $9 | $8.92 |
| Goodwill & intangible assets | $0.02 | $0.02 | $0.02 | |
| Total noncurrent assets | $9.44 | $10.05 | $9.83 | |
| Total investments | ||||
| Total assets | $11.3 | $15.3 | $17.56 | $15.37 |
| Current liabilities | ||||
| Accounts payable | $0.15 | $0.33 | $0.45 | $0.64 |
| Deferred revenue | ||||
| Short long term debt | $0.73 | $0.75 | $0.56 | |
| Total current liabilities | $2.08 | $3.02 | $4.09 | $2.91 |
| Long term debt | $3.43 | $3.55 | $3.69 | |
| Total noncurrent liabilities | $3.43 | $3.55 | $3.69 | |
| Total debt | $4.16 | $4.3 | $4.25 | |
| Total liabilities | $5.72 | $6.45 | $7.63 | $6.59 |
| Shareholders' equity | ||||
| Retained earnings | -$280.04 | -$273.8 | -$271.6 | -$270.71 |
| Other shareholder equity | ||||
| Total shareholder equity | $8.85 | $9.93 | $8.77 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $3.34 | $6.25 | $14.27 | $25.35 |
| Short term investments | ||||
| Net receivables | $0.69 | $0.33 | $0.1 | $1.9 |
| Inventory | $1.22 | $0.28 | $0.6 | $0.49 |
| Total current assets | $5.53 | $7.21 | $15.03 | $27.59 |
| Long term investments | ||||
| Property, plant & equipment | $8.92 | $8 | $6.41 | $2.4 |
| Goodwill & intangible assets | $0.02 | $0.03 | $0.03 | $0.04 |
| Total noncurrent assets | $9.83 | $8.56 | $6.81 | $2.86 |
| Total investments | ||||
| Total assets | $15.37 | $15.77 | $21.84 | $30.45 |
| Current liabilities | ||||
| Accounts payable | $0.64 | $0.43 | $0.22 | $0.19 |
| Deferred revenue | ||||
| Short long term debt | $0.56 | $0.9 | $0.5 | $0.51 |
| Total current liabilities | $2.91 | $8.08 | $2.21 | $2.88 |
| Long term debt | $3.69 | $0.37 | $1.9 | $1.76 |
| Total noncurrent liabilities | $3.69 | $1.99 | $1.9 | $1.76 |
| Total debt | $4.25 | $2.89 | $2.4 | $2.28 |
| Total liabilities | $6.59 | $10.07 | $4.11 | $4.64 |
| Shareholders' equity | ||||
| Retained earnings | -$270.71 | -$262.45 | -$249.88 | -$241.11 |
| Other shareholder equity | ||||
| Total shareholder equity | $8.77 | $5.7 | $17.73 | $25.8 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.8 | $0.86 | $0.69 | $0.9 |
| Cost of revenue | $0.56 | $0.5 | $0.63 | |
| Gross Profit | $0.59 | $0.29 | $0.19 | $0.27 |
| Operating activities | ||||
| Research & development | $1.68 | $2.02 | $1.82 | |
| Selling, general & administrative | $1.33 | $1.37 | $1.17 | |
| Total operating expenses | $2.13 | $3 | $3.39 | $2.99 |
| Operating income | -$2.71 | -$3.2 | -$2.72 | |
| Income from continuing operations | ||||
| EBIT | -$2.2 | -$0.88 | -$2.32 | |
| Income tax expense | ||||
| Interest expense | $0.19 | $0 | $0 | |
| Net income | ||||
| Net income | -$6.24 | -$2.2 | -$0.89 | -$2.32 |
| Income (for common shares) | -$2.2 | -$0.89 | -$2.32 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2.63 | $1.56 | $0.61 | $0.59 |
| Cost of revenue | $1.91 | $1.12 | $0.45 | $0.47 |
| Gross Profit | $0.71 | $0.44 | $0.16 | $0.12 |
| Operating activities | ||||
| Research & development | $8.71 | $6.45 | $5.89 | $4.81 |
| Selling, general & administrative | $5.36 | $5.33 | $4.89 | $3.81 |
| Total operating expenses | $14.07 | $11.78 | $10.78 | $8.62 |
| Operating income | -$13.36 | -$11.34 | -$10.62 | -$8.5 |
| Income from continuing operations | ||||
| EBIT | -$8.26 | -$12.02 | -$8.78 | -$7.03 |
| Income tax expense | ||||
| Interest expense | $0 | $0.02 | $0 | |
| Net income | ||||
| Net income | -$8.26 | -$12.04 | -$8.78 | -$7.03 |
| Income (for common shares) | -$8.29 | -$16.49 | -$8.78 | -$16.59 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$2.2 | -$0.89 | -$2.32 | |
| Operating activities | ||||
| Depreciation | $0.41 | $0.42 | $0.45 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.01 | $0.05 | $0.07 | |
| Total cash flows from operations | -$2.21 | -$2.73 | -$3.13 | |
| Investing activities | ||||
| Capital expenditures | -$0.32 | -$0.17 | -$0.06 | |
| Investments | $0.32 | |||
| Total cash flows from investing | -$0.2 | -$0.17 | -$0.06 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.11 | $2 | $0.34 | |
| Net borrowings | -$0.1 | -$0.04 | -$0.03 | |
| Total cash flows from financing | $9.2 | $1.01 | $5.33 | $0.31 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $1.47 | -$1.21 | $2.42 | -$2.88 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$8.26 | -$12.04 | -$8.78 | -$7.03 |
| Operating activities | ||||
| Depreciation | $1.66 | $0.96 | $0.65 | $0.5 |
| Business acquisitions & disposals | $0.3 | |||
| Stock-based compensation | $0.29 | $0.37 | $0.31 | $0.04 |
| Total cash flows from operations | -$14.12 | -$10.26 | -$10.13 | -$9.11 |
| Investing activities | ||||
| Capital expenditures | -$0.5 | -$1.4 | -$3.6 | -$0.36 |
| Investments | $1.94 | $2.11 | ||
| Total cash flows from investing | -$0.5 | -$1.1 | -$1.65 | $1.75 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $5.18 | $0.2 | $21.11 | |
| Net borrowings | -$0.11 | -$0.51 | $0.51 | $0.38 |
| Total cash flows from financing | $11.71 | $3.34 | $0.7 | $30.93 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$2.9 | -$8.03 | -$11.08 | $23.56 |
News
Fundamentals
| Market cap | $4.85M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 1.34M |
| Revenue | $3.25M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$11.65M |
| Revenue Q/Q | 17.85% |
| Revenue Y/Y | 30.40% |
| P/E ratio | -0.42 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 1.49 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$8.68 |
|---|---|
| ROA | -78.29% |
| ROE | N/A |
| Debt/Equity | 0.75 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.04 |
| Quick ratio | 2.82 |